MOPIX | VSMAX | MOPIX / VSMAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 38 years | 24 years | - |
Gain YTD | 0.897 | -0.304 | -295% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 295M | 161B | 0% |
Annual Yield % from dividends | 0.31 | 1.42 | 22% |
Returns for 1 year | 16.20 | 11.25 | 144% |
Returns for 3 years | 13.42 | 18.86 | 71% |
Returns for 5 years | 5.59 | 44.48 | 13% |
Returns for 10 years | 2.18 | 105.78 | 2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWVX | 72.83 | 1.47 | +2.06% |
Rydex Emerging Markets 2X Strategy H | |||
ETNHX | 34.51 | -0.36 | -1.03% |
Eventide Healthcare & Life Sciences N | |||
AMIDX | 13.46 | -0.15 | -1.10% |
Amana Developing World Institutional | |||
GSVSX | 16.24 | -0.25 | -1.52% |
Goldman Sachs Large Cap Value Svc | |||
OLVAX | 20.79 | -0.45 | -2.12% |
JPMorgan Large Cap Value A |